Načítá se...
Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour
BACKGROUND: Infantile inflammatory myofibroblastic tumour (IMT) is rare and the majority are driven by anaplastic lymphoma kinase (ALK) rearrangements. Previous literature on the use of ALK inhibitors in paediatric IMTs is extremely limited with no published literature on the use in infants. Crizoti...
Uloženo v:
| Vydáno v: | Ecancermedicalscience |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cancer Intelligence
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8057779/ https://ncbi.nlm.nih.gov/pubmed/33912240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2021.1215 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|